XML 26 R8.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Dec. 30, 2023
Cash flows from operating activities:      
Net earnings $ 295,992 $ 418,733 $ 514,457
Adjustments to reconcile net earnings to net cash from operating activities:      
Depreciation 138,360 124,641 110,563
Amortization of intangibles 22,691 23,521 21,327
Expense associated with share-based and grant compensation arrangements 37,792 38,163 34,899
Deferred income taxes 49,915 (15,382) (5,573)
Unrealized gain on investments and other (2,431) (1,217) (2,435)
Impairment of investments 6,500    
Equity in (earnings) loss of investee (709) (89) 2,367
Net loss (gain) loss on sale, disposition and impairment of assets 728 678 (260)
Impairment of goodwill and other intangibles 2,400 5,479  
Gain from reduction of estimated earnout liability (2,312) (2,460) (3,177)
Changes in:      
Accounts receivable 27,464 47,070 81,659
Inventories 7,291 6,356 250,561
Accounts payable and cash overdraft (20,190) 22,394 (3,578)
Accrued liabilities and other (17,754) (25,316) (40,920)
Net cash from operating activities 545,737 642,571 959,890
Cash flows used in investing activities:      
Capital expenditures (269,377) (232,274) (180,382)
Proceeds from sale of property, plant and equipment 31,472 11,501 3,291
Acquisitions and purchases of noncontrolling interest, net of cash received (17,626) (29,830) (52,383)
Purchases of investments (38,767) (55,397) (29,806)
Proceeds from sale of investments 19,953 30,844 29,935
Other 1,104 4,406 (10,819)
Net cash used in investing activities (273,241) (270,750) (240,164)
Cash flows used in financing activities:      
Borrowings under revolving credit facilities 34,426 29,913 28,462
Repayments under revolving credit facilities (38,133) (32,256) (30,125)
Repayments of debt   (40,000) (29)
Repayment of debt on behalf of investee   (6,303)  
Contingent consideration payments and other (221) (4,868) (6,262)
Proceeds from issuance of common stock 2,471 2,811 2,750
Dividends paid to shareholders (82,350) (80,782) (68,238)
Distributions to noncontrolling interest (3,005) (11,848) (7,355)
Purchase of remaining noncontrolling interest of subsidiary (549) (4,902)  
Payments to taxing authorities in connection with shares directly withheld from employees (9,591) (17,838)  
Repurchase of common stock (433,028) (141,120) (82,149)
Other (163) 73 86
Net cash used in financing activities (530,143) (307,120) (162,860)
Effect of exchange rate changes on cash 3,124 (7,363) 5,767
Net change in cash and cash equivalents (254,523) 57,338 562,633
Cash, cash equivalents, and restricted cash, beginning of period 1,179,594 1,122,256 559,623
Cash, cash equivalents, and restricted cash, end of period $ 925,071 $ 1,179,594 $ 1,122,256